Latest Industry Press Releases More...

We bring you the latest pharmaceutical press releases in our pharmaceutical Industry Press Releases section to help our clients gain great exposure on industry happenings. Know about mergers, deals, technology release, and other information first hand from press conferences of industry leaders with our Global pharmaceuticals Industry Press Releases.

Press Releases

Janssen-Cilag International NV announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for SYMTUZA™ (darunavir/cobicistat/emtricitabine/tenofovir alafenamide [D/C/F/TAF]), a once-daily darunavir-based single tablet regimen (STR). If approved, it will be the only darunavir-based STR indicated…

Press Releases

Churchill Pharmaceuticals, LLC, a privately held company devoted to expanding treatment options with oral oncology agents, announces that the New Drug Application (NDA) for YONSA™ (abiraterone acetate) ultramicrosize tablets has been accepted for filing by the U.S. Food and Drug Administration (FDA). Under the Prescription Drug User Fee Act (PDUFA),…

Press Releases

Novartis today announced that the US Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for AMG 334 (erenumab) for the prevention of migraine in patients experiencing four or more migraine days per month. If approved, erenumab is expected to be the first and only…

Press Releases

Oxford Global is pleased to share with you the final agenda for our highly anticipated Artificial Intelligence in Drug Development Congress taking place 27 – 28 September 2017 in London. Join us across two days to discuss with over 200 delegates the innovative application of artificial intelligence in drug development…

Press Releases

PersonalMed, LLC, has entered into a collaborative agreement with AmerisourceBergen’s pharmacy services administrative organization (PSAO), Elevate Provider Network, to introduce its pharmacy credentialing program. The program is available to the more than 4,500 independent pharmacies that participate in the Good Neighbor Pharmacy and Elevate Provider Network programs, and is focused…

Press Releases

Imago BioSciences, a clinical-stage pharmaceutical company developing novel anti-cancer therapies, announced today that the first patients have been dosed in the Phase 2a portion of their clinical trial of IMG-7289 for the treatment of high-risk acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS).  The company recently completed the Phase…

Press Releases

Today Lonza announced the release of a new FAQ Tech Tip, “Data Integrity for Endotoxin Testing” for its QC Insider™ Toolbox. Since data integrity is a fundamental component of the pharmaceutical industry, this new support tool will assist QC professionals who are performing bacterial endotoxin testing. Data integrity is the…

Press Releases

The 15th Annual Pharmaceutical IT Congress is an unmissable event for professionals seeking to increase their knowledge of the key topics and advancements impacting the industry. Join over 200 senior industry professionals and explore the key opportunities and challenges shaping the industry right now and discuss key areas such as…

Press Releases

A new series of leakproof vials has been developed to provide sample protection and user safety by enabling correct cap application every time. The unique lid-lock design of the Thermo Scientific Samco Clicktainer vials makes them ideal for the secure transport of valuable and often hazardous clinical, research and forensic…

Press Releases

DelMar Pharmaceuticals, a biopharmaceutical company focused on the development of new cancer therapies, today announced the completion of the first site initiation visit at the Dent Neurological Institute ("Dent") for its pivotal Phase 3 Study in Temozolomide-Avastin (bevacizumab) Recurrent GBM ("STAR-3").  Site initiation visits are generally the final step before…

loader